OncoCyte Corp reports results for the quarter ended September 30 - Earnings Summary

Insight Molecular Diagnostics

13/11/2024 14:15

* OncoCyte Corp  OCX.OQ  reported a quarterly adjusted loss
of 98
cents​​ per share for the quarter ended September 30, lower than
the same quarter last year, when the company reported EPS of -81
cents.  The mean expectation of three analysts for the quarter
was for a loss of 44 cents per share. Wall Street expected
results to range from -47 cents to -40 cents per share.
    * Revenue fell 73.2% to $115.00 thousand from a year ago;
analysts
expected $200.00 thousand. 
    * OncoCyte Corp's reported EPS for the quarter was a loss
of 98
cents​.
    * The company reported a quarterly loss of $13.49 million.
    * OncoCyte Corp shares had risen by 5.3% this quarter and
gained 20.0% so far this year.

FORECAST CHANGES
    * The mean earnings estimate of analysts had risen by
about 22.7%
in the last three months.​ 
    * In the last 30 days, there have been no earnings estimate
revisions by analysts covering the company.

RECOMMENDATIONS
    * The current average analyst rating on the shares is "hold"
and
the breakdown of recommendations is 1 "strong buy" or "buy," 2
"hold" and no "sell" or "strong sell." 
    * The average consensus recommendation for the biotechnology
&
medical research peer group is also "hold"

Wall Street's median 12-month price target for OncoCyte Corp is
4.13 
This summary was machine generated from LSEG data November 13 at
02:15 p.m. UTC. ​All figures in US dollars unless otherwise
stated. (For questions concerning the data in this report,
contact Estimates.Support@lseg.com. For any other questions or
feedback, contact RefinitivNewsSupport@thomsonreuters.com) QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Sep. 30 2024      -0.44          -0.98          Missed
 Jun. 30 2024      -0.56          -0.36          Beat
 Mar. 31 2024      -0.67          -1.13          Missed
 Dec. 31 2023      -1.14          -2.12          Missed